Philip C Bird, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1125 N Porter Ave, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 |
Robert Michael Holbrook, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1515 N Porter Ave, Suite 200, Norman, OK 73071 Phone: 405-366-8619 Fax: 405-366-1839 |
Satish K Arora, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1125 N Porter Ave, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 |
Mr. Charles Lee Lackey, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1515 N Porter Ave, Suite 200, Norman, OK 73071 Phone: 405-366-8619 |
Chintan A Parikh, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1125 N Porter Ave, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 |
Dr. Andrew William Black, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1125 N Porter Ave Ste 301, Norman, OK 73071 Phone: 405-360-2777 Fax: 405-360-2780 |
News Archive
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
A new treatment is the first to target the underlying genetic cause of AMD, which affects more than 600,000 people in the UK alone.
A single pain receptor is solely responsible for the kick delivered by mustard oil and garlic, according to research in the Cell. Mustard oil is the active ingredient in mustard and in the pungent green sushi condiment known as wasabi.
Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Prednisolone Sodium Phosphate Orally Disintegrating Tablets, 10 mg, 15 mg and 30 mg.
› Verified 7 days ago